Objectives: We investigated the influence of spinal cord stimulation (SCS) on IFN-, IL-1, IL-6, TNF-, IL-10, and TGF- serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN- and other cytokines in neuropathic pain (NP) development.
Materials And Methods: Clinical and biochemical assessment was conducted in four groups of patients: consisted of 24 FBSS patients qualified to SCS therapy, included 17 patients who were one month after implantation, featured 12 patients who were 3 months after the implantation, and (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN- were ascertained by an immunoenzymatic method.
Results: We found a significant difference between the patients before SCS and controls' serum level of IFN-. Similarly, a significantly higher level of TNF- and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls' serum level of IFN- and other cytokines. We noticed a positive correlation between IFN- concentration with NRS back value before SCS and positive correlation between IFN- concentration after SCS with NRS leg value before SCS. Higher IFN- concentrations accompanied higher NRS values. Levels of TGF- and IL-10 may correlate with physical ability and depressive behavior.
Conclusions: SCS did not influence serum cytokine levels significantly. Serum concentration of IFN- may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN- value accompanying higher pain intensity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348905 | PMC |
http://dx.doi.org/10.1155/2019/2606808 | DOI Listing |
Brain Sci
November 2024
Department of Neurosurgery, St. George's University Hospital, London SW17 0QT, UK.
Background: Spinal cord stimulation (SCS) has emerged as an effective treatment for managing chronic pain that is unresponsive to traditional therapies. While SCS is well documented for conditions like failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS), its effectiveness in managing pain related to spinal cord injuries (SCI) is less studied. This study aims to assess the efficacy of SCS in alleviating SCI-related pain and improving patients' quality of life, filling a gap in the existing literature.
View Article and Find Full Text PDFPain Physician
November 2024
Makous Research, LLC, Carlsbad, CA.
Orthopadie (Heidelb)
November 2024
Orthopädische Klinik, DIAKOVERE Annastift, Medizinischen Hochschule Hannover, Anna-von-Borries-Straße 1-7, 30625, Hannover, Deutschland.
The introduction of the term persistent spinal pain syndrome (PSPS), replacing the term failed back surgery syndrome (FBSS) has significantly changed diagnostic and treatment approaches of PSPS. There are multiple risk factors that may contribute to the development of PSPS. Accurately identifying individual risk factors is, therefore, crucial for patient-centered treatment planning.
View Article and Find Full Text PDFCureus
October 2024
Department of Musculoskeletal Sciences, Krishna College of Physiotherapy, Krishna Vishwa Vidyapeeth Deemed to be University, Karad, IND.
Background Failed back surgery syndrome (FBSS) mainly involves back pain radiating to the lower limb after back-related surgeries. It can develop various complications around the operation site and its surrounding area. This study evaluates the effect of lumbar spinal stabilization exercises and neural tissue mobilization on pain and spinal dysfunction in FBSS.
View Article and Find Full Text PDFPain Pract
January 2025
School of Medicine, China Medical University, Taichung, Taiwan.
Objectives: This single-arm, open-label, single-center observational pilot study assessed the safety and efficacy of ultrahigh-frequency dorsal root ganglia (UHF-DRG) stimulation in patients with chronic leg pain with or without low back pain. Such high-frequency electrostimulation had not been conducted in the human central nervous system previously.
Materials And Methods: The primary objective was to evaluate the safety of UHF-DRG stimulation (2 Hz pulses with 50 msec pulse-width and 500 kHz intrapulse sine waves, 5-min duration per stimulation) by identifying incident adverse events (AE) and severe adverse events (SAE) during the trial.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!